View Author
patient stroke infarction trial ck-mb nonhemorrhagic stroke mortality event study nonhemorrhagic elevation investigator baseline level heart treatment outcome predictor syndrome table hemorrhage pursuit model ratio result intervention troponin therapy 30 days angina 6- month mortality analysis death in-hospital 30- day mortality atrial fibrillation /flutter factor surgery end-point month treatment e ffect circulation america intracranial atrial creatine enzyme thrombolytic category site investigators intracranial hemorrhage percutaneou europe 30- group creatinine clearance multivariable hospital cardiol region epti fibatide heart rate peak ck-mb ratios effect /iiia pursuit trial heart failure creatinine glycoprotein value committee thrombolytic therapy thrombolysi peak ck-mb level califf rm fibrillation gusto-i clearance population history
10 Most Recent Publications
|
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years
(Article)
Chan, M.Y. Sun, J.L. Pieper, K.S. Giugliano, R.P. Armstrong, P.W. Califf, R.M. Werf, F.J.J. van de Harrington, R.A. Newby, L.K. Lokhnygina, Y. White, H.D. Moliterno, D.J. Theroux, P. Ohman, E.M. Simoons, M.L. Mahaffey, K.W. |
2012-02-16
|
|
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: Results from four large clinical trials
(Article)
Mahaffey, K.W. Roe, M.T. Kilaru, R. Alexander, J.H. Werf, F.J.J. van de Califf, R.M. Simoons, M.L. Topol, E.J. Harrington, R.A. |
2007-02-01
|
|
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
(Article)
Roe, M.T. Mahaffey, K.W. Lincoff, A.M. Califf, R.M. Topol, E.J. Werf, F.J.J. van de Alexander, J.H. Armstrong, P.W. Kilaru, R. Akkerhuis, K.M. Simoons, M.L. Harrington, R.A. Tardiff, B.E. Granger, C.B. Ohman, E.M. Moliterno, D.J. |
2004-02-01
|
|
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction
(Article)
Aviles, R.J. Newby, L.K. Jia, G. Ohman, E.M. Mahaffey, K.W. Califf, R.M. Lauer, M.S. Simoons, M.L. Berger, P. Topol, E.J. Askari, A.T. Lindahl, B. Wallentin, L.C. |
2002-01-01
|
|
Systematic adjudication of myocardial infarction end-points in an international clinical trial.
(Article)
Mahaffey, K.W. Harrington, R.A. Corbalon, R. Lee, K.L. Deckers, J.W. Simoons, M.L. Topol, E.J. Califf, R.M. Akkerhuis, K.M. Kleiman, N.S. Berdan, L.G. Crenshaw, B.S. Tardiff, B.E. Granger, C.B. Jong, I. de Bhapkar, M. Widimsky, P. |
2001-09-04
|
|
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction end-points in an international clinical trial: review of the PURSUIT study
(Article)
Mahaffey, K.W. Harrington, R.A. Corbalon, R. Lee, K.L. Deckers, J.W. Simoons, M.L. Topol, E.J. Califf, R.M. Akkerhuis, K.M. Kleiman, N.S. Berdan, L.G. Crenshaw, B.S. Tardiff, B.E. Granger, C.B. Jong, I. de Bhapkar, M. Widimsky, P. |
2001-09-04
|
|
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial
(Article)
Al-Khatib, S.M. Pieper, K.S. Califf, R.M. Harrington, R.A. Akkerhuis, K.M. Lee, K.L. Mahaffey, K.W. Hochman, J.S. Pepine, C.J. Kopecky, S. Stepinska, J. Simoons, M.L. Topol, E.J. |
2001-07-01
|
|
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT.
(Article)
Akkerhuis, K.M. Deckers, J.W. Simoons, M.L. Boersma, H. Harrington, R.A. Stepinska, J. Mahaffey, K.W. Wilcox, R.G. Lincoff, A.M. Keltai, M. Topol, E.J. Califf, R.M. |
2000-03-04
|
|
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation.
(Article)
Alexander, J.H. Chierchia, S.L. Ohman, E.M. Corbalan, R. Deckers, J.W. Boland, J.B. Harrington, R.A. Simoons, M.L. Topol, E.J. Califf, R.M. Sparapani, R.A. Mahaffey, K.W. Newby, L.K. |
2000-01-01
|
|
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study
(Article)
Tung, C.Y. White, H.D. Knight, J.D. Weaver, W.D. Mahaffey, K.W. Clapp-Channing, N. Mark, D.B. Simoons, M.L. Califf, R.M. Gore, J.M. Granger, C.B. Sloan, M.A. Topol, E.J. |
1999-01-01
|